Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Zytiga
Zytiga
Study: Hormone pill slows prostate cancer's growth
Yahoo/AP
Sun, 06/3/12 - 11:19 am
Zytiga
JNJ
prostate cancer
Is Dendreon's Downgrade Deserved?
Motley Fool
Wed, 05/30/12 - 10:20 am
Dendreon
downgrades
Provenge
prostate cancer
JNJ
Zytiga
J&J’s Zytiga Helps Eliminate Early-Stage Prostate Cancer
Bloomberg
Thu, 05/17/12 - 10:16 am
JNJ
Zytiga
prostate cancer
ASCO Preview: Eight Cancer Drugs to Watch at the Big Show
Xconomy
Wed, 05/16/12 - 12:27 pm
ASCO
Genentech
T-DM1
breast cancer
tivozanib
Aveo
kidney cancer
Onyx
Bayer
regorafenib
colorectal cancer
Adcetris
Seattle Genetics
JNJ
prostate cancer
Zytiga
cabozantinib
Exelixis
Enzalutamide
Medivation
Ponatinib
chronic myeloid leukemia
Ariad Pharmaceuticals
Dendreon does not see choice between Provenge and Jevtana/Zytiga as 'either/or'
Yahoo/Fly on the Wall
Wed, 03/14/12 - 10:45 am
Dendreon
Provenge
Jevtana
Zytiga
prostate cancer
Vical's Allovectin: Why Hasn't The Trial Been Stopped?
Seeking Alpha
Mon, 03/12/12 - 08:44 pm
Vical
Allovectin
metastatic melanoma
melanoma
Zytiga
JNJ
Dendreon Faces New Competition As J&J Impresses With Prostate Cancer Drug
Seeking Alpha
Sun, 03/11/12 - 12:12 pm
Zytiga
Provenge
prostate cancer
JNJ
Dendreon
J&J Prostate Cancer Drug Scores Big Win, Hurts Dendreon, Helps Medivation
TheStreet.com
Thu, 03/8/12 - 10:15 am
JNJ
prostate cancer
Dendreon
Provenge
Medivation
Zytiga
MDV3100
J&J’s Zytiga for Prostate Cancer Too Expensive, U.K. Cost Agency Says
Bloomberg
Thu, 02/2/12 - 09:12 am
JNJ
Zytiga
prostate cancer
UK
Dendreon's Provenge And JNJ's Zytiga Both Had Strong Early Sales
Seeking Alpha
Tue, 01/31/12 - 07:47 am
Dendreon
Provenge
prostate cancer
JNJ
Zytiga
Five Drugs That Own The Prostate Pipeline
Seeking Alpha
Tue, 11/8/11 - 11:00 am
prostate cancer
Dendreon
Provenge
Zytiga
JNJ
Medivation
MVD 3100
Exelixis
cabozantinib
Curtirsen
Teva Pharmaceuticals
OncoGenex
Analysis: New drugs drive prostate cancer market
Yahoo/AP
Mon, 09/19/11 - 06:08 pm
prostate cancer
Dendreon
Exelixis
JNJ
MDV3100
Medivation
Provenge
cabozatinib
Zytiga
J&J Aims For EU Approval For Prostate Cancer Drug
Investors.com
Tue, 08/23/11 - 07:23 pm
prostate cancer
JNJ
Zytiga
Europe
Street Still Underestimating J&J’s Pipeline: Citi
Barron's
Thu, 08/4/11 - 09:17 am
JNJ
pipelines
Zytiga
Xarelto
Incivo
J&J Wins European Panel’s Backing of Cancer, Hepatitis Drugs
Bloomberg
Sat, 07/23/11 - 04:32 pm
JNJ
Incivo
hepatitis C
Zytiga
prostate cancer
Weekend at ASCO: Drugs for Skin, Lung, Ovarian Cancer
WSJ Online
Mon, 06/6/11 - 09:27 pm
ASCO
melanoma
ovarian cancer
lung cancer
Pfizer
crizotinib
vemurafenib
JNJ
prostate cancer
Roche
Avastin
Zytiga
J&J’s Prostate Drug Extends Life as Spur to $5 Billion Market
Bloomberg
Thu, 06/2/11 - 10:25 am
prostate cancer
JNJ
Zytiga
Johnson & Johnson Touts Growth From New Drugs Zytiga, Edurant
Minyanville
Fri, 05/27/11 - 08:53 am
JNJ
Edurant
Zytiga
prostate cancer
HIV
AIDS
Pages
« first
‹ previous
1
2
3
4